The IL-1β-IL6-CRP axis constitutes a central inflammatory pathway in atherosclerosis and cardiovascular disease, where IL-1β serves as the upstream regulator that activates the NLRP3 inflammasome to induce ECs expression of adhesion molecules, thereby promoting inflammatory cell recruitment and macrophage activation. This evidence concerns the gene IL1B and cardiovascular disorder.